Peer-reviewedCC BY-NC-ND 4.0Nature Communications
Distinct T cell correlates of COVID-19 risk before and after a second booster in previously SARS-CoV-2 infected versus naïve COVAIL trial participants
Related
- Previously Unrecognized Distinct Laryngeal Lesions During Lazertinib Therapy in EGFR-Mutated NSCLC: A Case Series
- Beyond prevalence: distinct correlates of energy-drink use and consumption frequency in a cross-sectional study of undergraduate students in Dubai
- Multi-Dot/Icm effector mutants reveal distinct host responses in Legionella infected macrophages
- Safety and Preliminary Clinical Outcomes of Integrating Engineered Synthetic Lipid Vesicles (Biosomes) in a Skin Booster Protocol: A Prospective Observational Study
- Variant-specific and cross-reactive antibody responses following COVID-19 booster vaccinations and SARS-CoV-2 breakthrough infections
BibTeX
@article{zhang2026distinct,
title = {{Distinct T cell correlates of COVID-19 risk before and after a second booster in previously SARS-CoV-2 infected versus naïve COVAIL trial participants}},
author = {Bo Zhang and Youyi Fong and Chenchen Yu and Shiyu Chen and Valentin Voillet and Bhavesh Borate and Katharine Schwedhelm and Zhe Chen and Jing Wang and Nadine G. Rouphael and Angela R. Branche and David J. Diemert and Ann R. Falsey and Daniel S. Graciaa and Lindsey R. Baden and Sharon E. Frey and Jennifer A. Whitaker and Susan J. Little and Satoshi Kamidani and Emmanuel B. Walter and Richard M. Novak and Richard Rupp and Lisa A. Jackson and Craig A. Magaret and Lindsay N. Carpp and Tara M. Babu and Angelica C. Kottkamp and Anne F. Luetkemeyer and Lilly C. Immergluck and Rachel M. Presti and Martín Bäcker and Patricia L. Winokur and Siham M. Mahgoub and Paul A. Goepfert and Dahlene N. Fusco and Robert L. Atmar and Christine M. Posavad and Jinjian Mu and Mat Makowski and Mamodikoe K. Makhene and Seema U. Nayak and Paul C. Roberts and Dean Follmann and Stephen C. De Rosa and M. Juliana McElrath and Peter B. Gilbert and Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team},
journal = {Nature Communications},
year = {2026},
month = oct,
doi = {10.1038/s41467-026-78444-6},
url = {https://www.nature.com/articles/s41467-026-78444-6},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Distinct T cell correlates of COVID-19 risk before and after a second booster in previously SARS-CoV-2 infected versus naïve COVAIL trial participants
AU - Bo Zhang
AU - Youyi Fong
AU - Chenchen Yu
AU - Shiyu Chen
AU - Valentin Voillet
AU - Bhavesh Borate
AU - Katharine Schwedhelm
AU - Zhe Chen
AU - Jing Wang
AU - Nadine G. Rouphael
AU - Angela R. Branche
AU - David J. Diemert
AU - Ann R. Falsey
AU - Daniel S. Graciaa
AU - Lindsey R. Baden
AU - Sharon E. Frey
AU - Jennifer A. Whitaker
AU - Susan J. Little
AU - Satoshi Kamidani
AU - Emmanuel B. Walter
AU - Richard M. Novak
AU - Richard Rupp
AU - Lisa A. Jackson
AU - Craig A. Magaret
AU - Lindsay N. Carpp
AU - Tara M. Babu
AU - Angelica C. Kottkamp
AU - Anne F. Luetkemeyer
AU - Lilly C. Immergluck
AU - Rachel M. Presti
AU - Martín Bäcker
AU - Patricia L. Winokur
AU - Siham M. Mahgoub
AU - Paul A. Goepfert
AU - Dahlene N. Fusco
AU - Robert L. Atmar
AU - Christine M. Posavad
AU - Jinjian Mu
AU - Mat Makowski
AU - Mamodikoe K. Makhene
AU - Seema U. Nayak
AU - Paul C. Roberts
AU - Dean Follmann
AU - Stephen C. De Rosa
AU - M. Juliana McElrath
AU - Peter B. Gilbert
AU - Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team
PY - 2026
DA - 2026/10/06
JO - Nature Communications
DO - 10.1038/s41467-026-78444-6
UR - https://www.nature.com/articles/s41467-026-78444-6
SN - 2041-1723
ER -